News
A research group in Korea has discovered a novel natural antimicrobial peptide, "Hirunipin-2," from the salivary glands of ...
MRC Laboratory of Molecular Biology hands Constructive Bio a game-changer for next-gen tech roll-out
Constructive Bio in Cambridge now holds the exclusive licence to ‘tRNA Display’ technology from the MRC Laboratory of ...
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a ...
A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...
At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.
Anticipated AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025.
News-Medical.Net on MSN6d
New peptide therapy shows promise against glioblastoma recurrenceA lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...
Actym Therapeutics has strengthened its IP portfolio with two newly issued patents covering its novel STACT™ biological ...
Data completes preclinical package for Investigational New Drug submission in mid-2025 with Phase 1 therapeutic study ...
Researchers design a nanovaccine that detects MRSA toxins, kills bacteria with heat, and captures antigens to train the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback